Clinical Smoking Cessation Education Forum. Friday, November 3 rd, 2017 Fredericton, New Brunswick

Transcription

1 Clinical Smoking Cessation Education Forum Friday, November 3 rd, 2017 Fredericton, New Brunswick

2

3 WELCOME MESSAGE On behalf of Horizon Health Network s Centre of Excellence for Clinical Smoking Cessation (CoE), we would like to welcome everyone to the 2017 Clinical Smoking Cessation Education Forum. This year, the Forum brings together leaders from both tobacco control and tobacco cessation to share knowledge, expertise and build partnerships to support patients toward tobacco-free living. The most recent data from the Canadian Tobacco Alcohol and Drug Survey (CTADS) indicates smoking prevalence in New Brunswick has decreased from 19.6% (2012) to 14.2% (2015). Although the tobacco use prevalence for our province continues to be greater than the national average of 13% (CTADS, 2015), the decrease in our provincial prevalence is encouraging. However, tobacco addiction continues to be the leading cause of preventable disease, disability and death in North America (WHO, 2011). Jean Daigle Vice President Community Horizon Health Network Through Horizon Health Network s ongoing commitment to make smoking cessation a standard of care across the care continuum, there has been tremendous growth and success within our organization, with over 70 diverse health care settings implementing the Ottawa Model for Smoking Cessation (OMSC). A special thank you to both the planning committee for their efforts in organizing this event and to our outstanding speakers; your willingness to share your knowledge, experience and perspectives is greatly appreciated. Finally, to all participants, thank you for your continued leadership and clinical expertise in making this a priority for our organization and patients; our collective efforts are having a lasting impact on the health and wellbeing of the individuals, families and communities we serve.

4 PLANNING COMMITTEE Dr. Basil Blanchard Family physician, Rogersville Health Centre Dr. Michael Fleming B Sc., MD, CCFP, FCFP Director of Family Physician Programs in Continuing Professional Development Dalhousie University Faculty of Medicine Dr. Eshwar Kumar MBBS, FRCR Medical Officer New Brunswick Cancer Network Radiation Oncologist, Saint John Cancer Centre David Arbeau Director, Extramural and Public Health Upper River Valley Josh Scoville Outreach Facilitator, Centre of Excellence for Clinical Smoking Cessation Shelley Hewitson Outreach Facilitator, Centre of Excellence for Clinical Smoking Cessation Kelly Hurley Manager Centre of Excellence for Clinical Smoking Cessation Angela Liddle Registered Nurse Methadone Maintenance Clinic Fredericton Helen Norton Clinical Coordinator for Respiratory Therapy Dr. Everett Chalmers Hospital Glen Myers Clinical Pharmacist Moncton Oncology Clinic Amanda Gibson Registered Respiratory Therapist Miramichi Hospital Lorraine Legere Respiratory Therapist EMP Saint John Randy McKnight Manager of Radiation Therapy Saint John Cancer Centre Graeme Smith Manager, Fredericton Downtown Clinic and Fredericton Junction Community Health Centres ACCREDITATION As an accredited provider, Dalhousie University Continuing Professional Development designates this program for up to 6.5 credit hours for MAINPRO M1 of the College of Family Physicians of Canada and as a Section 1 accredited group learning activity of the Royal College of Physicians and Surgeons of Canada Educationally co-sponsored by: Continuing Professional Development

5 AGENDA FRIDAY NOVEMBER 3, 2017 Wu Conference Centre Fredericton, NB TIME TOPIC SPEAKERS 8:15 AM Registration and Continental Breakfast 8:45 AM Welcome Kelly Hurley 9:00 AM Introductory Comments David Arbeau 9:15 AM OMSC- Horizon Health Network Progress to date and future directions 9:30 AM Managing Smoking Cessation: No Smoker Left behind Describe the latest pharmacotherapy and behavioral treatment for addressing smoking cessation with all patients who smoke regardless of their readiness to quit, including the latest evidence for reduce to quit and smoking reduction strategies 10:30 AM Break 10:45 AM Tobacco Addiction Treatment in Clients with Co-Occurring Mental Illness and Addictions Discuss the importance of treatment of tobacco addiction in smokers with co-occurring disorders, with consideration of motivational, behavioral and pharmacologic treatments Describe supportive strategies to meet the needs of smokers with co-occurring mental health and substance use disorders 11:45 AM Lunch 12:30 PM Video/Q & A session 12:45 PM NB Drug Plans - Access to Smoking Cessation Therapy Review current eligibility criteria and coverage for stop smoking medications in New Brunswick Discuss the differences between the New Brunswick Provincial Drug Plan (NBPDP) and the Provincial Drug Plan (PDP) Explore potential initiatives for smoking cessation pharmacotherapy in New Brunswick 1:15 PM Plain Packaging, Tobacco Advertising, and Vapourised Nicotine Products: Understanding the Changing Tobacco Control Landscape in Canada Discuss the impact of tobacco industry advertising bans and the and the role of plain packaging for tobacco products Review the implication of e-cigarettes regulations in Canada and the impact on public health 2:15 PM Break 2:30 PM Q & A session 2:45 PM Smoking Cessation: A Contemporary Perspective Discuss the findings of the EAGLES study; the safety and efficacy of varenicline, bupropion, and the nicotine patch with or without psychiatric disorders Describe Canada s End Game ; examine recommendations aimed at reducing the rate of commercial tobacco use in Canada Kelly Hurley Dr. Robert Reid Dr. Peter Selby Dr. Heidi Liston Dr. David Hammond Dr. Andrew Pipe 3:45 PM Closing remarks Kelly Hurley

6 SPEAKER BIOGRAPHIES Robert Reid, PhD, MBA Deputy Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Dr. Robert Reid is Deputy Chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute, and a Professor in the Faculty of Medicine at the University of Ottawa. Dr. Reid is one of Canada s leading health behavior change experts, particularly concerning smoking cessation, physical activity promotion, dietary change and cardiovascular rehabilitation. He is a main inventor of the Ottawa Model for Smoking Cessation, a systematic approach to identifying and assisting smokers in clinical practice settings. His research is funded by the Canadian Institutes for Health Research, Heart and Stroke Foundation of Canada, the Canadian Cancer Society Research Institute, the Ontario Ministry of Health, and the Public Health Agency of Canada. David Hammond, PhD Professor & CIHR/PHAC Applied Public Health Chair School of Public Health & Health Systems, University of Waterloo David Hammond is a Professor in the School of Public Health & Health Systems at the University of Waterloo. His research focuses upon tobacco control policy in the areas of health communications, packaging, and product regulation, as well as nutritional labeling and obesity prevention. Professor Hammond works closely with regulators around the world and has served as an Advisor for the World Health Organization. He recently received the Canada s Premier Young Researcher Award from the Canadian Institutes of Health Research and is a past recipient of the Canadian Medical Association Journal s Top Canadian Achievements in Health Research Awards 2009 for his work with Geoff Fong and Mary Thompson as part of the International Tobacco Control Policy project, conducted in more than a dozen low and middle income countries.

7 Peter Selby, MBBS, CCFP, FCFP, MHSc, DipABAM, DFASAM Chief, Primary Care, Centre for Addiction and Mental Health (CAMH) Director of Medical Education, Centre for Addiction and Mental Health (CAMH) Clinician Scientist, Addictions Division, Centre for Addiction and Mental Health (CAMH) Professor, Departments of Family and Community Medicine and Psychiatry, and Dalla Lana School of Public Health, University of Toronto (416) ext Peter Selby MD is the Chief of Primary Care, Director of Medical Education, and a Clinician Scientist at the Centre for Addiction and Mental Health (CAMH). He is a Professor in the Departments of Family and Community Medicine, Psychiatry, and the Dalla Lana School of Public Health at the University of Toronto. He is also a Clinician Scientist in the Department of Family and Community Medicine. Dr. Selby is the Executive Director and creator of the TEACH project - a continuing education certificate program in Applied Counselling for Health with a focus on smoking cessation, through the University of Toronto. Dr. Selby s research, as a Principal Investigator at the Ontario Tobacco Research Unit, includes smoking cessation especially in smokers with co morbid conditions. As the Principal Investigator of the STOP Study, he investigates the effectiveness of NRT and counselling in different types of intervention settings. He is also the PI of CANADAPTT- a unique Canadian Smoking Cessation Guideline development and dissemination project. Dr. Selby also continues his clinical research with pregnant women who use substances and is the PI of a knowledge translation program (PREGNETS) to increase the adoption of evidence-based interventions with pregnant smokers. He has received grant funding totaling over 85 million dollars from CIHR, NIH, and Ministry of Health and has published 135 peer reviewed publications. He has published 5 books (including 4 edited), is the author of 30 book chapters, and 32 research reports prepared for the government. He is the Chair of the Canadian Centre on Substance Abuse National Task Force on Treatment for Prescription Drug Misuse and the Chair of the Medical Education Council for the American Society of Addiction Medicine. Dr. Selby mentors Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators and medical students. The use of innovative methods to communicate messages makes Dr. Selby a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change.

8 Heidi L. Liston, BSc (Pharm), PharmD Director, Drug Utilization and Presciption Monitoring Program Pharmaceutical Services, New Brunswick Department of Health Dr. Heidi Liston has over 20 years of pharmacy related experience and is responsible for the evaluation of drug utilization for New Brunswick in order to support evidence-based, cost-effective drug prescribing policies and practices. She is also responsible for the implementation of the Prescription Monitoring Program for the province. Heidi s prior experience includes roles in psychiatric pharmacy practice, medical education development and delivery, pharmaceutical industry, and research. She has a keen interest in strategies to manage change at both the policy and practice level that produce optimal outcomes for patients. Heidi led the development and implementation of the NB Pharmacheck Medication Review program. She participates on several committees at a federal level including the Prescription Monitoring Program Network and CADTH s Optimal Use Working Group. She has been a guest lecturer for the UNB Nurse Practitioner, Advanced Pharmacotherapeutics class on Chronic Non-Cancer Pain Management. Heidi received a Bachelor of Science in Pharmacy from Dalhousie University. She also completed a Doctor of Pharmacy at the Medical University of South Carolina (MUSC), and a Psychiatric Pharmacy Residency and Psychopharmacology Research Fellowship through the Department of Psychiatry and Behavioral Sciences, at MUSC, in Charleston, SC. Dr. Andrew Pipe, CM, BA, MD, LLD (Hons), DSc (Hons) Division of Prevention and Rehabilitation, University of Ottawa Heart Institute Professor, Faculty of Medicine, University of Ottawa Dr. Andrew Pipe graduated from Queen s University in Formerly Chief of the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute, Dr. Pipe is a Professor in the Faculty of Medicine at the University of Ottawa. Dr. Pipe continues his clinical and research activities within the Division. He is currently involved in clinical research assessing new approaches to smoking cessation, strategies designed to facilitate exercise adoption, and novel initiatives to prevent cardiovascular disease. Dr. Pipe has addressed audiences in over 30 nations and is frequently consulted on issues related to tobacco use and smoking cessation, drug use in sport, and physical activity and health. In addition to his clinical responsibilities, Dr. Pipe has been extensively involved in sports and sport medicine for many years. Dr. Pipe served as a physician at 12 Olympic Games and has been the Team Physician for Canada s National Men s Basketball Team since A member of the Canadian Olympic Hall of Fame, he served as Chair of the Canadian Centre for Ethics in Sport from its inception until Dr. Pipe is the recipient of the International Olympic Committee s Award for Sport, Health and Wellbeing and honourary degrees from Queen s University (LLD), Brock University (DSc) and University of Guelph (DSc). He was formerly Vice Chairman of the Board of Trustees at Queen s University. In 2002 he was named to the Order of Canada.

9 DISCLOSURE OF CONFLICT OF INTEREST The Office of Continuing Medical Education supports the CMA Policy Summary on Physicians. Among other standards, it is now accepted practice to acknowledge potential conflicts of interest in CME activities. The Office requires that all speakers disclose pertinent relationships they have with commercial organizations. A conflict of interest may exist if a speaker is affiliated with, or has a financial interest in commercial organizations that may have a direct or indirect interest in the subject matter of his/her presentation. A financial interest may include but is not limited to, being a shareholder in the organization, or having research or honoraria paid by the organization. An affiliation may be holding a position on an advisory committee or some other role of benefit to an organization. The intent of disclosure is not to prevent a speaker with potential conflicts of interest from making a presentation but simply to make these known to the audience. With full disclosure of the pertinent relationships, participants may make their own conclusions about potential bias in presentations. The following speakers have declared financial interest, or affiliation including receipt of honoraria or expenses with a commercial organization that may have a direct or indirect connection to the content of their presentation. Dr. Robert Reid - Pfizer Inc., Johnson & Johnson - Member of Speakers bureau - Pfizer Inc. - Currently participating in or have participated in a clinical trial within the past two years Dr. Peter Selby - Pfizer Inc., Johnson & Johnson - Member of advisory board or equivalent with a commercial organization - Pfizer Inc., Johnson & Johnson, Bristol-Myers Squibb, Miller Medical Communications, Evidera Inc., NVision Insight Group, and Medican Clinic - Received or will receive a grants or an honorarium from a commercial organization - Pfizer Inc. - Currently participating in or have participated in a clinical trial within the past two years Dr. Heidi Liston - Therapeutic Research Centre - Received payment from a commercial organization (including gifts or other consideration or in-kind compensation) Dr Andrew Pipe - Pfizer Inc., Johnson & Johnson - Member of Speakers bureau - Pfizer Inc., Johnson & Johnson - Received or will receive a grants or an honorarium from a commercial organization The following speakers declared that they had no financial interests, arrangement and/or affiliations with organizations sponsoring this program Dr. David Hammond

10 SMOKING CESSATION RESOURCES Canadian Cancer Society Prenets Canadian Council for Tobacco Control Canadian Public Health Agency Centre for Addiction and Mental Health Health Canada gc.ca/tobacco Heart and Stroke Foundation Leave the Pack Behind MyQuit New Brunswick Anti-Tobacco Coalition Ontario s Anesthesiologists: Stop Smoking for Safer Surgery Centre of Excellence for Clinical Smoking Cessation Smoker s Helpline Tobacco-Free Futures The Tobacco Atlas The Training Enhancement in Applied Cessation Counseling and health (TEACH) The Program Training and Consultation Centre The Lung Association Stop Smoking Centre Society of Research on Nicotine and Tobacco Quitnet Ontario Tobacco Research Unit Ottawa Model for Smoking Cessation Propel: Centre for Population Health Impact

11 A special thank you to: Notes

12